

HY-149352 · 50 mg
MedChemExpress · Cat: HY-149352
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/dg1.html
Description
DG1 Compound 8Nc is a Thymidylate Synthase TS inhibitor that affects cancer angiogenesis and metabolic reprogramming in NSCLC cells. DG1 can effectively inhibit the expression of CD26, ET-1, FGF-1 and EGF. DG1 also effectively inhibits the proliferation of cancer tissue in the A549 xenograft mouse model.







